Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
In a move to focus on its fastest growing brands and enhance shareholders’ return, Nike, Inc. ( NKE - Analyst Report ) intends to divest its two wholly-owned brands, Umbro and Cole Haan. The company revealed that it will start the divestiture process immediately and hopes to complete by the end of May 2013.
Nike is the industry leader by a stretch in the U.S. footwear and athletic apparel industry.Over the years, the company has acquired many well known brands to further strengthen its leadership position. These brands include Converse Inc., which designs, markets and distributes athletic footwear, apparel and accessories; Cole Haan, a leading designer and marketer of luxury shoes, handbags, accessories and coats; Hurley International LLC, which designs, markets and distributes action sports and youth lifestyle footwear, apparel and accessories; and Umbro Ltd. a leading U.K.-based global soccer brand.
We believe the reason behind the divestiture is that Cole Haan and Umbro’s performance does not match with the performance of Nike’s other brands. During the third quarter of 2012, Nike's total revenue grew 15.1% to $5,846 million from $5,079 million in the prior-year quarter, primarily driven by growth in all key categories of NIKE Brand, and in geographic regions excluding Japan. Revenue for the quarter surpassed the Zacks Consensus Estimate of $5,829 million.
Our Recommendation
We believe the company’s decision to divest its two underperforming brands will boost its bottom line. Meanwhile,in an attempt to expand its global reach and market share, Nike is capitalizing on growth opportunities in emerging markets, especially China. The company is focusing on other tools, such as a direct-to-consumer business model, to expand geographically. We believe that Nike’s continued investment in China and focus on the direct-to consumer business will not only help in expanding market share, but will also facilitate in strengthening its competitive position.
However, sluggish discretionary spending and intense competition amid rapidly changing customer preferences keep us on the sidelines.
Nike competes with PVH Corporation ( PVH - Snapshot Report ) and Brown Shoe Company Inc. ( BWS - Snapshot Report ) . Currently, the company maintains a Zacks #2 Rank, which translates into a short-term Buy rating. However, we retain a long-term 'Neutral' recommendation on the stock.
Read the full Analyst Report on NKE
Read the full Snapshot Report on PVH
Read the full Snapshot Report on BWS